Details for Patent: 8,522,778
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 8,522,778 protect, and when does it expire?
Patent 8,522,778 protects XHANCE and is included in one NDA.
This patent has one hundred and fifty-seven patent family members in twenty-six countries.
Summary for Patent: 8,522,778
| Title: | Nasal devices |
| Abstract: | A nasal delivery device for and a method of delivering a substance to a nasal cavity of a subject, the delivery device including: a nosepiece for fitting to a nostril of a subject; a substance supply unit for supplying a substance for delivery through the nosepiece; and a delivery prevention mechanism for preventing delivery of a substance through the nosepiece until the nosepiece is properly fitted to the nostril of the subject. |
| Inventor(s): | Djupesland; Per Gisle (Oslo, NO) |
| Assignee: | OptiNose AS (Oslo, NO) |
| Application Number: | 12/757,626 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; Device; |
Recent additions to Drugs Protected by US Patent 8,522,778
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist Req. | Patent Expiration | Usecode | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Optinose Us Inc | XHANCE | fluticasone propionate | SPRAY, METERED | 209022 | Sep 18, 2017 | RX | Yes | See Plans and Pricing | Y | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Type | >RLD | >Patent No. | >Product | >Substance | >Delist Req. | >Patent Expiration | >Usecode | >Patented / Exclusive Use |
Drugs Protected by US Patent 8,522,778
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Optinose Us Inc | XHANCE | fluticasone propionate | SPRAY, METERED;NASAL | 209022-001 | Sep 18, 2017 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,522,778
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 0104692.9 | Feb 26, 2001 |
| PCT/IB2002/001546 | Feb 26, 2002 | |
International Family Members for US Patent 8,522,778
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 285810 | See Plans and Pricing | |||
| Austria | 422923 | See Plans and Pricing | |||
| Austria | 427130 | See Plans and Pricing | |||
| Austria | 487506 | See Plans and Pricing | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
